Key Market Indicator:
F&G: 54
25.587,16 NASDAQ · 49.369,01 DOW · 6.933,85 S&P · 4.913,96 Gold · 63,92 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© PR Newswire
10.06.2024
ISIN: GB00BN4HT335
Indivior PLC
INDV
LISTED
NASDAQ
Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder
Article
News Preview
Double-blind, placebo-controlled study aims to measure safety and efficacy of INDV-2000 over 3 months in participants with moderate to severe Opioid Use Disorder.INDV-2000 is an investigational non-opioid treatment that acts through the orexin pathway, shown to play a key role in the neurobiology of substance use disorder in animals.Recent animal...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.06.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Results of the Annual General Meeting 2024
Article
News Preview
  Most agenda items adopted with great majority Annual General Meeting 2024 elects Dr Duncan McHale and Wesley Wheeler to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka   Hamburg, Germany, 10 June 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.06.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Ergebnisse der Hauptversammlung 2024
Article
News Preview
  Die meisten Tagesordnungspunkte mit großer Mehrheit beschlossen Hauptversammlung 2024 wählt Dr. Duncan McHale und Wesley Wheeler in den Aufsichtsrat; Dr. Elaine Sullivan und Dr. Mario Polywka scheiden aus dem Aufsichtsrat aus   Hamburg, 10. Juni 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; ......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
10.06.2024
ISIN: US00507W2061
Actinium Pharmaceuticals Inc
ATNM
LISTED
XASE
Actinium Highlights Mutation Data from the Phase 3 SIERRA Trial of Iomab-B and Novel Linker Technology to Support Solid Tumor Antibody Radiation Conjugate Development at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
Article
News Preview
Iomab-B led bone marrow transplant improved survival in patients with high-risk relapsed or refractory acute myeloid leukemia including those with a TP53 mutationIomab-B safely delivered radiation to the target bone marrow at greater amounts than achievable with total body irradiation while sparing healthy non-target organs and enabled 100% acces...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
10.06.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
07.06.2024
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
Article
News Preview
Press Release Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00 Berlin, June 7, 2024 – Hauck & Aufhäuser Investment Banking initiated coverage of Medios AG yesterday and recommended the shares as a “buy”. The price target is €23.00 and thus around 55 percent above the Xetra closing price on ......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.06.2024
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Hauck & Aufhäuser startet Coverage der Medios AG mit Kaufempfehlung und Kursziel von 23,00 €
Article
News Preview
Pressemitteilung Hauck & Aufhäuser startet Coverage der Medios AG mit Kaufempfehlung und Kursziel von 23,00 € Berlin, 7. Juni 2024 – Hauck & Aufhäuser Investment Banking hat gestern die Coverage der Medios AG aufgenommen und die Aktien zum Kauf („Buy“) empfohlen. Das Kursziel liegt bei 23,00 € und damit rund 55 Prozent über dem Xetra-Schl......
Themefolio
Profiler
Peergroup
© Globe Newswire
07.06.2024
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
Article
News Preview
Company announcement - No. 30 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
ISIN: FR0014008VX5
Euroapi S.A.
EAPI
LISTED
EURONEXT
Market update : FOCUS-27 transformation project financing
Article
News Preview
Press release...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
Article
News Preview
CONSHOHOCKEN, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced results from new analyses of the Phase 3 MAESTRO-NASH trial of Rezdiffra being presented at the EASL Congress, which takes...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.06.2024
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
Article
News Preview
Press release Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe Berlin, June 06, 2024 – Medios, a leading provider of Specialty Pharma in Europe, has completed the acquisition of Ceban Pharmaceuticals B.V. (“Ceban”), a fast-growing, leading pharmaceutical compounding platform with operati......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.06.2024
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
Article
News Preview
Press release Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe Berlin, June 06, 2024 – Medios, a leading provider of Specialty Pharma in Europe, has completed the acquisition of Ceban Pharmaceuticals B.V. (“Ceban”), a fast-growing, leading pharmaceutical compounding platform with operati......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
06.06.2024
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Medios AG schließt Übernahme von Ceban erfolgreich ab und baut damit Marktposition in Europa deutlich aus
Article
News Preview
Pressemitteilung Medios AG schließt Übernahme von Ceban erfolgreich ab und baut damit Marktposition in Europa deutlich aus Berlin, 06. Juni 2024 – Medios, ein führender Anbieter von Specialty Pharma in Europa, hat die Übernahme von Ceban Pharmaceuticals B.V. („Ceban“), eine schnell wachsende, führende pharmazeutische Compounding-Plattform mit Tä......
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees
Article
News Preview
 ...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
ISIN: FR0014008VX5
Euroapi S.A.
EAPI
LISTED
EURONEXT
EUROAPI reaches major Health IPCEI milestone with official notification from European Commission
Article
News Preview
Paris – June 6, 2024 – EUROAPI has received official notification from the European Commission that the Company has been selected as one of the 13 companies eligible to share up to EUR 1 billion in total public funding under the Important Project of Common European Interest (IPCEI) dedicated to the pharmaceutical sector, “IPCEI Med4Cure”....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
ISIN: IE000LK2BOB4
Mural Oncology PLC
MURA
LISTED
NASDAQ
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
Article
News Preview
WALTHAM, Mass. and DUBLIN, June 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that Caroline Loew, Ph.D., CEO, will present at the...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN führt Assay-Design-Tool für digitale PCR Plattform QIAcuity ein und erweitert Anpassungsmöglichkeiten in Forschungsplattform GeneGlobe
Article
News Preview
Neues Custom Assay Design Tool für digitale PCR-Plattform QIAcuity zur Anylayse von Kopienzahlvariationen unterstützt individuelle Bedürfnisse von Forschern und ergänzt QIAGENs bestehende vorgefertigte Assays // GeneGlobe Design- und Analyse-Hub erhält weitere Funktionen zur Verbesserung der Benutzerfreundlichkeit und gemeinsamen Erstellung von Pan...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
Article
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Article
News Preview
CONSHOHOCKEN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024, and will present at 8:40 A.M. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2024
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant
Article
News Preview
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2024
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
Article
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2024
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
Article
News Preview
MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Med...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
03.06.2024
ISIN: GB00BMX86B70
Haleon PLC
HLN
LISTED
LSE
Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition
Article
News Preview
BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (LSE / NYSE: HLN). This trans...
Themefolio
Profiler
Peergroup
© Newsfile
03.06.2024
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX
Article
News Preview
Dublin, Ireland--(Newsfile Corp. - June 3, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) with its Cosmo Intelligent Medical Devices division (“Cosmo IMD”) is consolidating its strategy to accelerate the adoption of responsible and regulated AI in healthcare, obtaining pragmatic results in its...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2024
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN erweitert QIAstat-Dx-Menü in den USA mit syndromischem Test für bessere Versorgung bei Magen-Darm-Erkrankungen
Article
News Preview
QIAstat-Dx Gastrointestinal Panel 2 von der FDA in den USA zur klinischen Anwendung zugelassen // Neues Panel erkennt bis zu 16 gängige Erreger von Magen-Darm-Erkrankungen schnell und genau // Generiert Ergebnisse innerhalb rund einer Stunde, basierend auf Echtzeit-PCR-Technologie; ermöglicht einfachen Zugang zu Ct-Werten und Amplifikationskurven Q...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.06.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
Article
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.06.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
Article
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.06.2024
ISIN: US45258D1054
Immunocore Holdings plc
IMCR
LISTED
NASDAQ
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
Article
News Preview
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response...
Themefolio
Profiler
Peergroup
© Newsfile
01.06.2024
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024
Article
News Preview
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - May 31, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its final audited results for the financial year 2023. Financial highlights As previously announced when publishing preliminar...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ISIN: US45258D1054
Immunocore Holdings plc
IMCR
LISTED
NASDAQ
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024
Article
News Preview
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
Article
News Preview
COPENHAGEN, Denmark, May 31, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of a freeze-dried formulation of JYNNEOS® for prevention of smallpox and mpox disease in adults 18 years of age and older....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency
Article
News Preview
Press release – No. 6 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Announces Plan to Implement ADS Ratio Change
Article
News Preview
Châtillon, France, May 31, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ISIN: NL0015000DX5
Atai Life Sciences N.V.
ATAI
LISTED
NASDAQ
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
Article
News Preview
NEW YORK and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the Company’s management team will participate in the Jefferies Global Healthcare Conference being held from Ju...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.05.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Trading by management and close relations of management
Article
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© EQS Newswire
31.05.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler Hosts Second Radionuclide Theranostics Forum in Boston, MA
Article
News Preview
BOSTON, Mass., May 31, 2024 – Eckert & Ziegler reports about the successful completion of the 2nd annual Boston Radionuclide Theranostics Forum, reaffirming its pivotal role in the field of radiopharmaceuticals. Building on the momentum of last year's inaugural event, the Forum once again brought together leading experts, potential and existing......
Themefolio
Profiler
Peergroup
© EQS Newswire
31.05.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler veranstaltet zweites Radionuklid-Theranostik-Forum in Boston, MA
Article
News Preview
BOSTON, Massachusetts, 31. Mai 2024 – Eckert & Ziegler freut sich über die erfolgreiche Durchführung des zweiten Boston Radionuclide Theranostics Forum, das seine zentrale Rolle im Bereich der Radiopharmazie erneut unter Beweis gestellt hat. Aufbauend auf der Dynamik der letztjährigen Eröffnungsveranstaltung brachte das Forum erneut führende Ex......
Themefolio
Profiler
Peergroup
© EQS Newswire
31.05.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler veranstaltet zweites Radionuklid-Theranostik-Forum in Boston, MA
Article
News Preview
BOSTON, Massachusetts, 31. Mai 2024 – Eckert & Ziegler freut sich über die erfolgreiche Durchführung des zweiten Boston Radionuclide Theranostics Forum, das seine zentrale Rolle im Bereich der Radiopharmazie erneut unter Beweis gestellt hat. Aufbauend auf der Dynamik der letztjährigen Eröffnungsveranstaltung brachte das Forum erneut führende Ex......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2024
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Provides Business and Corporate Update
Article
News Preview
OSE Immunotherapeutics Provides Business and Corporate Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2024
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
Article
News Preview
MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it plans to initiate a Phase 3 clinical trial to evaluate gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
Article
News Preview
  Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics Lille University Hospital will provide human biological samp......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
Article
News Preview
  Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics Lille University Hospital will provide human biological samp......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital und Inserm Transfert arbeiten zusammen, um neue therapeutische Ziele bei Adipositas und Stoffwechselerkrankungen zu identifizieren
Article
News Preview
  Partnerschaft wird Evotecs molekulare Patientendatenbank im Bereich Stoffwechselerkrankungen und insbesondere Adipositas erweitern Evotec wird ihre führende PanOmics-Technologie für die Generierung von großen Omics-Datensätzen, einschließlich Transkriptomik, Proteomik und Metabolomik, einsetzen Lille University Hospital wird biologi......
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ISIN: FR0004163111
Genfit SA
GNFT
LISTED
EURONEXT
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
Article
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed its presence at the EASL Congress™ 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
Article
News Preview
Published open-access today in Nature Genetics, “High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing” identifies novel evidence of a proximity bias in CRISPR-Cas9 gene knockouts and a debiasing (correcting) algorithm. Published open-access today in Nature Genetics, “High-resolution genome-wide mapp...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024
Article
News Preview
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
Article
News Preview
Press release – No. 5 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Trading by management and close relations of management
Article
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the  transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B in the attach...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ISIN: US74039M3097
Predictive Oncology, Inc.
POAI
LISTED
NASDAQ
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
Article
News Preview
Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners through early oncologic drug discovery Presentation to highlight Company’s novel application of AI/machine learning capabilities utilizing its proprietary...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ISIN: US45258D1054
Immunocore Holdings plc
IMCR
LISTED
NASDAQ
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
Article
News Preview
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2024
ISIN: BE0974283153
Mithra Pharmaceuticals S.A.
MITRA
LISTED
EURONEXT
Mithra postpones its annual general meeting
Article
News Preview
Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that in the context of the monetization process and the uncertainties related thereto, Mithra postpones its Annual General Shareholders’ Meeting, previously planned for 30 May 2024, to a later date to be determined. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2024
ISIN: US74039M3097
Predictive Oncology, Inc.
POAI
LISTED
NASDAQ
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Article
News Preview
Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
Article
News Preview
  Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease One of Evotec’s largest strategic drug discovery alliances   Hamburg, Germany, 28 May 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
Article
News Preview
  Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease One of Evotec’s largest strategic drug discovery alliances   Hamburg, Germany, 28 May 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec und CHDI Foundation verlängern strategische Huntington-Allianz
Article
News Preview
  Langjährige Allianz zwischen Evotec und CHDI zur Entwicklung von Therapeutika für die Huntington-Krankheit Eine der größten strategischen Wirkstoffforschungs-Allianzen von Evotec   Hamburg, 28. Mai 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute die Verlängerung ihrer 20......
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2024
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development invests in BOOST Pharma, expanding its portfolio
Article
News Preview
STOCKHOLM, SWEDEN – May 28, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the company has invested in BOOST Pharma – a company based on research from Karolinska Institutet that develops a first-in-class and potentially groundbreaking cell-based treatment of the rare bone disease osteogenesis imperfecta, also known as...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.05.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer baut Kapazitäten für Medical Systems in den USA aus
Article
News Preview
Gerresheimer baut Kapazitäten für Medical Systems in den USA aus Zweistufiger Ausbau des Standortes Peachtree City, Georgia Gesamtinvestitionsvolumen von rund 180 Mio. USD Über 400 neue Arbeitsplätze für Fachkräfte aus der Region Produktionsstart ab Ende 2024 Düsseldorf / Peachtree City, USA, 27. Mai 2024. Gerresheimer, innovativer System- und ......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.05.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer expands capacities for Medical Systems in the USA
Article
News Preview
Gerresheimer expands capacities for Medical Systems in the USA Two-stage expansion of the Peachtree City, Georgia site Total investment volume of around USD 180 million More than 400 new jobs for skilled workers from the region Ramp-up of production beginning end of 2024 Düsseldorf / Peachtree City, USA, May 27, 2024 – Gerresheimer, an innovati......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 23.01.2026, Calendar Week 04, 23rd day of the year, 342 days remaining until EoY.